Tag: Pharmaceuticals

Depression Drug Vyvanse Sent Back To Drawing Board
The pharmaceutical group Shire has decided to stop d...
Read More
Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims
The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has...
Read More
Merck Job Cuts On the Rise, Cuts Could Prove Beneficial
For months, the struggling New Jersey- based pharmaceutical conglomerate has been struggling, and the numbers they've been producing have only made their financial woes more eviden...
Read More
Purdue, Maker of OxyContin, Keeps a List of Bad Docs
Earlier this year, the FDA made headlines when it prevented pharmaceutical giant Purdu...
Read More
Cholesterol Drug Tredaptive Pulled Worldwide
Less than one month ago, Merck, a major U.S. pharmaceutical company, announced that its cholesterol drug...
Read More
Diabetes Drug Approved by U.S. FDA Committee
A U.S. Food and Drug Administration (FDA) committee this week approved the drug canagliflozin for the treatment of adults with...
Read More
Diabetes Drug Works Differently Than Was Previously Thought
For half a century one of the most popular and most-prescribed classes of diabetes drugs has been biguanides, which include...
Read More
Stroke Medication Approved by the U.S. FDA
A new anti-clotting drug has been approved by the U.S. Food and Drug Administration. Called apixaban and marketed by Bristol-...
Read More
Merck Drug Fails Major Clinical Trial
Merck, a major U.S. pharmaceutical company, announced this wee...
Read More
Cholesterol Meds Most Effective With Exercise, Shows Study
A new study shows that cholesterol-lowering drugs have a more significant effect when combined with exercise. Though both the...
Read More
Grapefruit Warning For Medications Expanded
A review published this week in the Canadian Medical Association Journal (CMAJ) warns that while the number of...
Read More
Diabetes Treatment Shown to Improve Memory For Alzheimer’s Patients
A new study shows that a drug used to treat insulin resistance in diabetics could improve cognitive performance in some peo...
Read More
Asthma Drug Rejected by U.K.’s NICE
The U.K.'s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an...
Read More
Arthritis Drug Approved by the U.S. FDA
The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to...
Read More
Multiple Sclerosis Drug ‘Reboots’ the Immune System
New trials show that a cancer drug can be an effective treatment for multiple sclerosis (MS) by 'rebooting' patients' immune systems. The results of two phase III clinical trials...
Read More
Get the WebProNews newsletter delivered to your inbox

Get the free daily newsletter read by decision makers

Subscribe
Advertise with Us

Ready to get started?

Get our media kit

Advertise with Us